Clinical trial
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg…
NCT00427960 · AstraZeneca, Industry · Terminated
Key facts
| NCT number | NCT00427960 |
|---|---|
| Title | Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg |
| Official title | A Phase IV, 6-week, Randomised, Double-blind, Multicentre, Parallel Group, Comparative Study to Evaluate the Efficacy of Rosuvastatin 5mg and Atorvastatin 10mg in UK Asian Subjects With Primary Hypercholesterolaemia |
| Lead sponsor | AstraZeneca, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypercholesterolaemia |
| Intervention type | Behavioral, Drug |
| Interventions | Dietary advice, rosuvastatin, atorvastatin |
| Enrollment | 55 |
| Start date | Dec 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Jan 29, 2007 |
| Last update posted | Dec 16, 2010 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: